We found that pancreatic cancer cell lines, 85% of which present with KRAS mutations, were significantly more dependent on KRAS than were all other cell lines (t = 35.4, p = 2.8 × 10−178; Fig. 4e). This evidence concerns the gene KRAS and familial pancreatic carcinoma.